The FDA has approved Hercessi (trastuzumab-strf), a biosimilar to Herceptin (trastuzumab). The FDA has approved Hercessi (trastuzumab-strf), a biosimilar to Herceptin (trastuzumab).
FDA approves Hercessi as latest interchangeable Herceptin biosimilar healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.